FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2059316621> ?p ?o ?g. }

• W2059316621 endingPage "1548" @default.
• W2059316621 startingPage "1540" @default.
• W2059316621 abstract "Highest attack rates for influenza occur in children. Immunization of schoolchildren with inactivated influenza vaccine in Michigan and Japan was associated with decreased morbidity and mortality, respectively, in older community contacts. An open-labeled, non-randomized, community-based trial in children with the cold adapted influenza vaccine, trivalent (CAIV-T) was initiated to determine the coverage necessary to reduce spread of influenza in the community. Age-specific baseline rates of medically attended acute respiratory illness (MAARI) for Scott and White Health Plan (SWHP) members at intervention (Temple and Belton) and comparison communities (Waco, Bryan, and College Station) were obtained in 1997–1998. During three subsequent vaccination years, 4298, 5251 and 5150 children received one dose per season of CAIV-T. Vaccinees represented 20–25% of the age-eligible children. Age-specific MAARI rates were compared for SWHP members in the intervention and comparison sites during the influenza outbreaks. Baseline age-specific MAARI rates per 100 persons for the influenza season were comparable between the intervention and comparison communities. In the subsequent three influenza seasons, the age groups 35–44, 45–54, 55–65 and >64 years experienced reductions in MAARI rates in the intervention communities. In adults ≥35 years of age, significant reductions in MAARI of 0.08 (95% CI: 0.04, 0.13), 0.18 (95% CI: 0.14, 0.22) and 0.15 (95% CI: 0.12, 0.19), were observed in the influenza seasons for vaccination years 1, 2 and 3, respectively. No consistent reduction in MAARI rates was detected in the younger age groups. Vaccination of approximately 20–25% of children, 1.5–18 years of age in the intervention communities resulted in an indirect protection of 8–18% against MAARI in adults ≥35 years of age." @default.
• W2059316621 created "2016-06-24" @default.
• W2059316621 creator A5001489839 @default.
• W2059316621 creator A5013180357 @default.
• W2059316621 creator A5020467223 @default.
• W2059316621 creator A5022356831 @default.
• W2059316621 creator A5024874733 @default.
• W2059316621 creator A5025082697 @default.
• W2059316621 creator A5037638028 @default.
• W2059316621 creator A5040201315 @default.
• W2059316621 creator A5061988295 @default.
• W2059316621 creator A5080221460 @default.
• W2059316621 creator A5089400401 @default.
• W2059316621 date "2005-02-01" @default.
• W2059316621 modified "2023-10-17" @default.
• W2059316621 title "Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children" @default.
• W2059316621 cites W1956161579 @default.
• W2059316621 cites W1963594199 @default.
• W2059316621 cites W1969338473 @default.
• W2059316621 cites W1970389789 @default.
• W2059316621 cites W1973871284 @default.
• W2059316621 cites W1977775160 @default.
• W2059316621 cites W1979045904 @default.
• W2059316621 cites W1986335202 @default.
• W2059316621 cites W1990817586 @default.
• W2059316621 cites W1994187772 @default.
• W2059316621 cites W2004425622 @default.
• W2059316621 cites W2009722009 @default.
• W2059316621 cites W2027393202 @default.
• W2059316621 cites W2040210640 @default.
• W2059316621 cites W2042015698 @default.
• W2059316621 cites W2045759312 @default.
• W2059316621 cites W2047562582 @default.
• W2059316621 cites W2062956415 @default.
• W2059316621 cites W2065420324 @default.
• W2059316621 cites W2091080683 @default.
• W2059316621 cites W2094461948 @default.
• W2059316621 cites W2116396562 @default.
• W2059316621 cites W2135456251 @default.
• W2059316621 cites W2138064535 @default.
• W2059316621 cites W2139841187 @default.
• W2059316621 cites W2144861190 @default.
• W2059316621 cites W2145230724 @default.
• W2059316621 cites W2168525324 @default.
• W2059316621 cites W2312219549 @default.
• W2059316621 cites W2336491233 @default.
• W2059316621 doi "https://doi.org/10.1016/j.vaccine.2004.09.025" @default.
• W2059316621 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15694506" @default.
• W2059316621 hasPublicationYear "2005" @default.
• W2059316621 type Work @default.
• W2059316621 sameAs 2059316621 @default.
• W2059316621 citedByCount "260" @default.
• W2059316621 countsByYear W20593166212012 @default.
• W2059316621 countsByYear W20593166212013 @default.
• W2059316621 countsByYear W20593166212014 @default.
• W2059316621 countsByYear W20593166212015 @default.
• W2059316621 countsByYear W20593166212016 @default.
• W2059316621 countsByYear W20593166212017 @default.
• W2059316621 countsByYear W20593166212018 @default.
• W2059316621 countsByYear W20593166212019 @default.
• W2059316621 countsByYear W20593166212020 @default.
• W2059316621 countsByYear W20593166212021 @default.
• W2059316621 countsByYear W20593166212022 @default.
• W2059316621 countsByYear W20593166212023 @default.
• W2059316621 crossrefType "journal-article" @default.
• W2059316621 hasAuthorship W2059316621A5001489839 @default.
• W2059316621 hasAuthorship W2059316621A5013180357 @default.
• W2059316621 hasAuthorship W2059316621A5020467223 @default.
• W2059316621 hasAuthorship W2059316621A5022356831 @default.
• W2059316621 hasAuthorship W2059316621A5024874733 @default.
• W2059316621 hasAuthorship W2059316621A5025082697 @default.
• W2059316621 hasAuthorship W2059316621A5037638028 @default.
• W2059316621 hasAuthorship W2059316621A5040201315 @default.
• W2059316621 hasAuthorship W2059316621A5061988295 @default.
• W2059316621 hasAuthorship W2059316621A5080221460 @default.
• W2059316621 hasAuthorship W2059316621A5089400401 @default.
• W2059316621 hasConcept C106192422 @default.
• W2059316621 hasConcept C116675565 @default.
• W2059316621 hasConcept C126322002 @default.
• W2059316621 hasConcept C144024400 @default.
• W2059316621 hasConcept C149923435 @default.
• W2059316621 hasConcept C159047783 @default.
• W2059316621 hasConcept C187212893 @default.
• W2059316621 hasConcept C203014093 @default.
• W2059316621 hasConcept C22070199 @default.
• W2059316621 hasConcept C2779134260 @default.
• W2059316621 hasConcept C2780689484 @default.
• W2059316621 hasConcept C2780801004 @default.
• W2059316621 hasConcept C2909469553 @default.
• W2059316621 hasConcept C3008058167 @default.
• W2059316621 hasConcept C524204448 @default.
• W2059316621 hasConcept C71924100 @default.
• W2059316621 hasConcept C8891405 @default.
• W2059316621 hasConcept C89623803 @default.
• W2059316621 hasConceptScore W2059316621C106192422 @default.
• W2059316621 hasConceptScore W2059316621C116675565 @default.
• W2059316621 hasConceptScore W2059316621C126322002 @default.
• W2059316621 hasConceptScore W2059316621C144024400 @default.

• next